JPMorgan stock drops as Trump sues Jamie Dimon — and Fed week looms
23 January 2026
1 min read

JPMorgan stock drops as Trump sues Jamie Dimon — and Fed week looms

NEW YORK, Jan 23, 2026, 10:46 AM EST — Regular session

Shares of JPMorgan Chase & Co (JPM) dropped 1.7% to $298.45 in Friday’s morning session after President Donald Trump filed a $5 billion lawsuit accusing the bank and CEO Jamie Dimon of politically motivated “debanking,” or closing accounts. The stock began the day at $302, briefly dipping to $298.38. JPMorgan pushed back, calling the lawsuit baseless and stating it closes accounts only when there’s legal or regulatory risk. 1

The legal blow comes as Trump pushes Congress to cap credit card interest rates at 10% for a year, hitting a key revenue source for major banks. At the World Economic Forum in Davos, Dimon called the move an “economic disaster” that would cut off credit for 80% of Americans. Brian Jacobsen, chief economic strategist at Annex Wealth Management, said it’s “highly unlikely we’ll see a 10% cap put in place anytime soon.” 2

JPMorgan is taking a more aggressive stance in wealth management. Edmund Cohen, head of pensions and wealth products, revealed in an internal memo that the bank has finalized the purchase of UK pensions tech platform WealthOS. The plan includes integrating its UK and Sri Lanka teams into the operation to enhance its pensions services via J.P. Morgan Personal Investing. 3

Rivals are plotting their own responses if Washington moves forward. Bank of America is mulling new credit cards capped at a 10% rate, with Citigroup exploring similar offerings, according to a source familiar with the situation. This comes after the White House provided little clarity on how any rate cap would actually be enforced. 4

Bank stocks slipped broadly, dragging the KBW Nasdaq Bank Index down roughly 1.4% during the session. 5

Investors are watching to see if the lawsuit fades quickly or sparks a drawn-out battle over banks’ customer screening and reputational risk controls. Moves by regulators to adjust standards in either direction could send shockwaves through the industry.

The road ahead is far from clear. A court might dismiss the case quickly, or it could drag on through discovery, leaving Dimon and the bank caught in a political storm. A harsher ruling—like new restrictions on card fees or account closures—would strike earnings more sharply than any legal bills.

Federal Reserve officials meet next week on Jan. 27-28, with their policy decision set for 2 p.m. EST on Jan. 28, followed by a press briefing half an hour later. Investors watch rate guidance closely—it shapes forecasts for banks’ lending margins and loan demand. 6

Stock Market Today

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

Applied Digital stock jumps 25% as AI data-center names rebound — what’s next for APLD

7 February 2026
Applied Digital Corporation shares jumped 25.52% Friday to $34.95, then slipped to $34.60 after hours. The company reported fiscal Q2 revenue up 250% to $126.6 million and signed leases for 600 MW of data center capacity in North Dakota. Applied Digital broke ground on a new 430‑MW campus in the southern U.S. in January. Financing includes a $100 million promissory note with 8% interest, paid in kind.
Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Google stock price today: Alphabet GOOG Class C ticks up as judge keeps search antitrust suit alive
Previous Story

Google stock price today: Alphabet GOOG Class C ticks up as judge keeps search antitrust suit alive

Palantir stock price rises as retail ETF spotlight lands ahead of Fed week and earnings
Next Story

Palantir stock price rises as retail ETF spotlight lands ahead of Fed week and earnings

Go toTop